BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 17221336)

  • 1. Treatment of autoimmune disease: time for a paradigm shift?
    Mor F
    Arch Immunol Ther Exp (Warsz); 2007; 55(1):13-8. PubMed ID: 17221336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunology in medical practice. XIX. Etiology and pathogenesis of auto-immune diseases].
    de Vries RR; Roep BO
    Ned Tijdschr Geneeskd; 1999 May; 143(19):974-8. PubMed ID: 10368716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current concepts and diagnostic evaluation of autoimmune disease.
    Nakamura RM; Binder WL
    Arch Pathol Lab Med; 1988 Sep; 112(9):869-77. PubMed ID: 3046557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic use of T regulatory cells.
    Verbsky JW
    Curr Opin Rheumatol; 2007 May; 19(3):252-8. PubMed ID: 17414951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutics for future treatment of uveitis].
    Deschênes J
    Bull Soc Belge Ophtalmol; 2000; 276():7-11. PubMed ID: 10925522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated 0.5-Gy gamma irradiation attenuates autoimmune disease in MRL-lpr/lpr mice with suppression of CD3+CD4-CD8-B220+ T-cell proliferation and with up-regulation of CD4+CD25+Foxp3+ regulatory T cells.
    Tago F; Tsukimoto M; Nakatsukasa H; Kojima S
    Radiat Res; 2008 Jan; 169(1):59-66. PubMed ID: 18159952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On reversing the persistence of memory: hematopoietic stem cell transplant for autoimmune disease in the first ten years.
    Deane S; Meyers FJ; Gershwin ME
    J Autoimmun; 2008 May; 30(3):180-96. PubMed ID: 18242059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of the current use of rituximab in autoimmune diseases.
    Gürcan HM; Keskin DB; Stern JN; Nitzberg MA; Shekhani H; Ahmed AR
    Int Immunopharmacol; 2009 Jan; 9(1):10-25. PubMed ID: 19000786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo expansion of CD4(+)CD25(+) T regulatory cells for immunosuppressive therapy.
    Trzonkowski P; Szaryńska M; Myśliwska J; Myśliwski A
    Cytometry A; 2009 Mar; 75(3):175-88. PubMed ID: 18855921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory T cells in health and disease.
    Rouse BT
    J Intern Med; 2007 Jul; 262(1):78-95. PubMed ID: 17598816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease.
    Miller SD; Turley DM; Podojil JR
    Nat Rev Immunol; 2007 Sep; 7(9):665-77. PubMed ID: 17690713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B cell-directed therapies for autoimmune disease and correlates of disease response and relapse.
    Levesque MC; St Clair EW
    J Allergy Clin Immunol; 2008 Jan; 121(1):13-21; quiz 22-3. PubMed ID: 18206502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B cell targeted therapy in autoimmunity.
    Blank M; Shoenfeld Y
    J Autoimmun; 2007; 28(2-3):62-8. PubMed ID: 17391915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy and bone marrow stem-cell transfer to treat autoimmune disease.
    Alderuccio F; Chan J; Scott DW; Toh BH
    Trends Mol Med; 2009 Aug; 15(8):344-51. PubMed ID: 19665432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical effects and safety of rituximab for treatment of refractory pediatric autoimmune diseases.
    El-Hallak M; Binstadt BA; Leichtner AM; Bennett CM; Neufeld EJ; Fuhlbrigge RC; Zurakowski D; Sundel RP
    J Pediatr; 2007 Apr; 150(4):376-82. PubMed ID: 17382113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+CD25+FoxP3+ regulatory T cells in autoimmune diseases.
    Valencia X; Lipsky PE
    Nat Clin Pract Rheumatol; 2007 Nov; 3(11):619-26. PubMed ID: 17968332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroid treatments in mice do not alter the number and function of regulatory T cells, but amplify cyclophosphamide-induced autoimmune disease.
    Moraes-Fontes MF; Rebelo M; Caramalho I; Zelenay S; Bergman ML; Coutinho A; Demengeot J
    J Autoimmun; 2009 Sep; 33(2):109-20. PubMed ID: 19362805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A therapeutic anti-CD4 monoclonal antibody inhibits T cell receptor signal transduction in mouse autoimmune cardiomyopathy.
    Wang ZH; Liao YH; Yuan J; Zhang L; Wang M; Zhang JH; Liu ZP; Dong JH
    Chin Med J (Engl); 2007 Aug; 120(15):1319-25. PubMed ID: 17711737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A modified vaccination technique for the prevention and treatment of an experimental autoimmune kidney disease.
    Barabas AZ; Cole CD; Barabas AD; Lafreniere R
    Ann N Y Acad Sci; 2007 Sep; 1110():619-29. PubMed ID: 17911477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.